Sept 1 (Reuters) - QuiaPEG Pharmaceuticals Holding AB
QUIA.ST :
* CONDUCTS DISCUSSIONS WITH PHARMACEUTICAL COMPANIES THAT
HAVE
EXPRESSED WISH TO USE UNI-QLEAVER
* SUCH DISCUSSIONS MAY RESULT IN EVALUATION AGREEMENTS WHICH
SUBSEQUENTLY LEAD TO LICENSE AGREEMENTS WITH UP-FRONT PAYMENTS,
MILESTONE PAYMENTS AND ROYALTIES
* CO'S OBJECTIVE IS THAT ONE OR SOME OF THE ONGOING
DISCUSSIONS
SHOULD MATERIALIZE IN LATTER PART OF THIS YEAR OR AT BEGINNING
OF NEXT YEAR
Source text for Eikon: ID:nMFNyb2tS
Further company coverage: QUIA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))